Accueil › Leucémie aiguë myéloïde › New Jersey › Edison
Essais cliniques pour Leucémie aiguë myéloïde à Edison, NJ
20 études pour Leucémie aiguë myéloïde recherchent des participants dans et autour de Edison (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Recrutement en coursPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
A Study of CRD3874-SI in People With Leukemia
Recrutement en coursPhase 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · à 15 mi
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Recrutement en coursPhase 3
- Saint Peter's University Hospital, New Brunswick · à 3 mi
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · à 3 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Recrutement en coursPhase 1/2
- Saint Peter's University Hospital, New Brunswick · à 3 mi
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · à 3 mi
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Recrutement en coursPhase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · à 3 mi
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Recrutement en coursPhase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recrutement en coursÉtude observationnelle
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · à 3 mi
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · à 15 mi
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Recrutement en coursPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study of Revumenib and Mezigdomide in People With Leukemia
Recrutement en coursPhase 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · à 15 mi
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Recrutement en coursPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recrutement en coursPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · à 3 mi
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Recrutement en coursPhase 1
- Rutgers Cancer Institute, New Brunswick · à 3 mi
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Recrutement en coursPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · à 15 mi
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · à 15 mi
Essais pour Leucémie aiguë myéloïde dans d'autres villes
- Houston, TX85 études
- New York City, NY51 études
- Boston, MA44 études
- Baldwin Park, CA40 études
- Seattle, WA40 études
- Columbus, OH35 études
- Philadelphia, PA34 études
- Durham, NC33 études
- Atlanta, GA30 études
- Tampa, FL29 études
- Chicago, IL26 études
- Portland, OR25 études
Autres études à Edison
- Cancer du sein68 études
- Cancer du poumon non à petites cellules47 études
- Cancer (tous types)33 études
- Cancer de la prostate29 études
- Cancer colorectal23 études
- Cancer du poumon23 études
- Myélome multiple22 études
- Cancer de la vessie21 études
- Cancer métastatique20 études
- Cancer de l'ovaire20 études
- Cancer de l'endomètre19 études
- Carcinome urothélial (à cellules transitionnelles)18 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.